{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:21Z","timestamp":1753890621077,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Deliv."],"abstract":"<jats:p>Recombinant protein vaccines offer an advantage without a safety risk in eliciting desired humoral and cell-mediated immune responses against infectious diseases. But one of their disadvantages is their low immunogenicity, thus requiring adjuvants that augment their immunogenicity. It is necessary to explore new technology that could provide a non-toxic, biodegradable, and biocompatible delivery system with adjuvant characteristics and nanotechnology provides an excellent platform for nanomaterial-based vaccine adjuvants. Here, we have synthesized a modified dipeptide, Arg-\u03b1, <jats:italic>\u03b2<\/jats:italic>-dehydrophenyalanine (R\u0394F) containing \u0394F at its C-terminal, and characterized it using reversed-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry techniques. R\u0394F upon its self-assembly to spherical nanoparticles (NPs) efficiently condensed a recombinant <jats:italic>Plasmodium falciparum<\/jats:italic> surface protein, histidine-tagged MSPFu24 (Fu24H). The morphological characteristics of the nanoparticle formulation was characterized using TEM. R\u0394F NPs and R\u0394F-Fu24H complex showed excellent <jats:italic>in vitro<\/jats:italic> biocompatibility toward two mammalian cell lines and human red blood cells (RBCs). Furthermore, mice treated with R\u2206F NPs showed histological and haematological properties similar to the untreated control group which indicated their very high <jats:italic>in vivo<\/jats:italic> biocompatibility. Mice treated with R\u0394F-Fu24H nanoformulation induced a high titers of anti-Fu24H specific antibodies and showed a mixed Th1 and Th2 profile, comparable to the FDA-approved adjuvant Alhydrogel<jats:sup>\u00ae<\/jats:sup>. The sera from immunized mice inhibited the erythrocyte invasion activity of <jats:italic>P. falciparum\u2019s<\/jats:italic> laboratory line 3D7 <jats:italic>in vitro<\/jats:italic> which was comparable to that of Alhydrogel<jats:sup>\u00ae<\/jats:sup>. The present study suggests that the highly biocompatible dipeptide-based nanoparticle formulation can further be developed and used in clinic as a promising antigen delivery platform to elicit immune responses.<\/jats:p>","DOI":"10.3389\/fddev.2023.1135209","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:53:28Z","timestamp":1682484808000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Modified dipeptide based nanospheres as a potent adjuvating delivery system for recombinant vaccines"],"prefix":"10.3389","volume":"3","author":[{"given":"Saikat","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Somanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paushali","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virander Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.2147\/IJN.S33015","article-title":"Novel dipeptide nanoparticles for effective curcumin","volume":"7","author":"Alam","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/vaccines9070782","article-title":"Production and immunogenicity of a tag-free recombinant chimera based on PfMSP-1 and PfMSP-3 using alhydrogel and dipeptide-based hydrogels","volume":"9","author":"Anand","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/vaccines10111946","article-title":"Nanoparticle-based delivery systems for vaccines","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Vaccines (Basel)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther. Deliv."},{"key":"B6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1021\/tx500479m","article-title":"Nanotoxicity of silver nanoparticles to red blood cells: Size dependent adsorption, uptake, and hemolytic activity","volume":"28","author":"Chen","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: Putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008"},{"key":"B9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.addr.2016.06.013","article-title":"Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering","volume":"110","author":"Eskandari","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/vaccines10050819","article-title":"An overview of vaccine adjuvants: Current evidence and future perspectives","volume":"10","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines (Basel)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1016\/j.vaccine.2016.09.044","article-title":"Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus","volume":"34","author":"Friedrich","year":"2016","journal-title":"Vaccine X."},{"key":"B12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1128\/CVI.00179-14","article-title":"Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24","volume":"21","author":"Gupta","year":"2014","journal-title":"PfMSP-Fu24"},{"key":"B13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nantod.2016.02.004","article-title":"Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery","volume":"11","author":"Habibi","year":"2016","journal-title":"Nano Today"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010"},{"key":"B15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nmat3775","article-title":"Engineering synthetic vaccines using cues from natural immunity","volume":"12","author":"Irvine","year":"2013","journal-title":"Nat. Mat."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9138","DOI":"10.1021\/la401556k","article-title":"Surface and size effects on cell interaction of gold nanoparticles with both phagocytic and nonphagocytic cells","volume":"29","author":"Liu","year":"2013","journal-title":"Langmuir"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0065-3233(05)70003-6","article-title":"The structure of alpha-helical coiled coils","volume":"70","author":"Lupas","year":"2005","journal-title":"Adv. Protein Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00441-018-2929-4","article-title":"Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action","volume":"374","author":"Magiri","year":"2018","journal-title":"Cell Tissue Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1128\/IAI.00427-09","article-title":"Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: Immunogenicity determined with human-compatible adjuvants and induction of protective immune response","volume":"78","author":"Mazumdar","year":"2010","journal-title":"Infect. Immun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1021\/la7034533","article-title":"Nanovesicles based on self-assembly of conformationally constrained aromatic residue containing amphiphilic dipeptides","volume":"24","author":"Mishra","year":"2008","journal-title":"Langmuir"},{"key":"B22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1590\/s0100-879x2011007500064","article-title":"Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants","volume":"44","author":"Miyaji","year":"2011"},{"key":"B23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1124\/pr.111.005363","article-title":"Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles","volume":"64","author":"Morachis","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.biotechadv.2017.05.002","article-title":"Harnessing self-assembled peptide nanoparticles in epitope vaccine design","volume":"35","author":"Negahdaripour","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1021\/nn3057005","article-title":"Gold nanoparticles as a vaccine platform: Influence of size and shape on immunological responses in vitro and in vivo","volume":"7","author":"Niikura","year":"2013","journal-title":"ACS Nano"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1039\/C4PY00173G","article-title":"Short peptide based self-assembled nanostructures: Implications in drug delivery and tissue engineering","volume":"5","author":"Panda","year":"2014","journal-title":"Polym. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4155\/tde.10.93","article-title":"Designed peptides as model self-assembling nanosystems: Characterization and potential biomedical applications","volume":"2","author":"Panda","year":"2011","journal-title":"Ther. Deliv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.2217\/nnm.12.201","article-title":"Modified dipeptide-based nanoparticles: Vehicles for targeted tumor drug delivery","volume":"8","author":"Panda","year":"","journal-title":"Nanomed"},{"key":"B29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-3155-11-18","article-title":"Self-assembled nanoparticles based on modified cationic dipeptides and DNA: Novel systems for gene delivery","volume":"11","author":"Panda","year":"","journal-title":"J. Nanobiotechnology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"175632","DOI":"10.1016\/j.ejphar.2023.175632","article-title":"Adjuvants approved for human use: What do we know and what do we need to know for designing good adjuvants?","volume":"945","author":"Reyes","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fbioe.2019.00197","article-title":"Nanotheranostics targeting the tumor microenvironment","volume":"7","author":"Roma-Rodrigues","year":"2019","journal-title":"Nanotheranostics Target. tumor Microenviron."},{"key":"B33","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1073\/pnas.0912124107","article-title":"A self-assembling peptide acting as an immune adjuvant","volume":"107","author":"Rudra","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acs.accounts.6b00579","article-title":"In situ characterization of protein adsorption onto nanoparticles by fluorescence correlation spectroscopy","volume":"50","author":"Shang","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.7150\/thno.30577","article-title":"Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy","volume":"9","author":"Song","year":"2019","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.4049\/jimmunol.174.5.2573","article-title":"IFN regulatory factor-4 and-8 govern dendritic cell subset development and their functional diversity","volume":"174","author":"Tamura","year":"2005","journal-title":"J. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"31167","DOI":"10.1038\/srep31167","article-title":"A novel highly stable and injectable hydrogel based on a conformationally restricted ultrashort peptide","volume":"6","author":"Thota","year":"2016","journal-title":"Sci. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.29643","article-title":"Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice","volume":"67","author":"Varshney","year":"2018","journal-title":"Hepatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1021\/acs.molpharmaceut.1c00451","article-title":"Delivery of a cancer-testis antigen-derived peptide using conformationally restricted dipeptide-based self-assembled nanotubes","volume":"18","author":"Verma","year":"2021","journal-title":"Mol. Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1021\/acs.bioconjchem.8b00483","article-title":"Protein\u2013polymer delivery: Chemistry from the cold chain to the clinic","volume":"29","author":"Welch","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1039\/c9bm01304k","article-title":"Short to ultrashort peptide-based hydrogels as a platform for biomedical applications","volume":"8","author":"Yadav","year":"2020","journal-title":"Biomater. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/nnm-2022-0144","article-title":"Conformationally restricted, dipeptide-based, self-assembled nanoparticles for efficient vancomycin delivery","volume":"17","author":"Yadav","year":"2022","journal-title":"NANOMEDICINE"}],"container-title":["Frontiers in Drug Delivery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddev.2023.1135209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:53:30Z","timestamp":1682484810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddev.2023.1135209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":42,"alternative-id":["10.3389\/fddev.2023.1135209"],"URL":"https:\/\/doi.org\/10.3389\/fddev.2023.1135209","relation":{},"ISSN":["2674-0850"],"issn-type":[{"type":"electronic","value":"2674-0850"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"article-number":"1135209"}}